Viewing Study NCT01284192


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-01-31 @ 12:11 PM
Study NCT ID: NCT01284192
Status: COMPLETED
Last Update Posted: 2016-06-28
First Post: 2011-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module